SLNO EBITDA Margin

Soleno Therapeutics Inc · EBITDA Margin

SLNO logo

SLNO EBITDA Margin

Latest reported37.55%
SLNO EBITDA Margin (0.00% → 37.55%)
High-resolution chart · PNG

SLNO ebitda margin history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Soleno Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
14.9066%
0%
0%
0%
0%
0%
0%
0%
0.7618%
-463.0531%
-4,076.9215%
0%
-26.8286%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.